Search Results 921-930 of 16372 for monoclonal antibody

1. A Study of Cell, Serum, and Bone Marrow Bank for Patients receiving Chimeric Antigen Receptor T Cell Therapy for the Treatment of Cancer - Mayo Clinic

   ... antibodies and the factors that may determine disease progression and treatment response. ... Plan to initiate treatment with either bi-specific antibody or CAR-T ...

2. A Study to Evaluate EAA181 to Treat Newly-diagnosed Multiple Myeloma - Mayo Clinic

   ≥ 200 mg/24 hours of monoclonal protein on a 24-hour urine protein electrophoresis. ... Monoclonal bone marrow plasmacytosis ≥ 30% (evaluable disease).

3. A Multicenter Assessment of ALD403 in Chronic Migraine - Mayo Clinic

   Receipt of any monoclonal antibody treatment within 6 months of screening (within or outside a clinical trial); Previously dosed with ALD403 or any ...

4. A Study to Assess the Culture, PCR, Serology and Symptoms of COVID-19 - Mayo Clinic

   Consent waived. Topic 6 - Isolation of human peripheral blood mononuclear cells (PBMC) for development of human monoclonal antibodies, and investigation of HLA ...

5. Safety and Efficacy Study of Gevokizumab to Treat Active Non-infectious Uveitis - Mayo Clinic

   History of allergic or anaphylactic reactions to monoclonal antibodies; Active tuberculosis disease; History of recurrent infection or predisposition to ...

6. Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in NSCLC With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer - Mayo Clinic

   ... antibody Patients in Expansion Phase, Cohorts 2 and 3; Previously ... Prior anti-cancer monoclonal antibody (mAb) within 4 weeks prior to baseline ...

7. Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps

   Any experimental monoclonal antibody (mAB) within 5 half-lives or within 6 months before V1 if the half-life is unknown. Anti-immunoglobulin E therapy ...

8. A Study to Investigate Intravenous Tocilizumab in Patients with Moderate-to-Severe COVID-19 Pneumonia (enrolling by invitation only) - Mayo Clinic

   Known severe allergic reactions to TCZ or other monoclonal antibodies;; Active TB infection;; Suspected active bacterial, fungal, viral, or other infection ...

9. Overview - Mayo Clinic

   Monoclonal gammopathy-associated conditions including C1-esterase inhibitor deficiency, cryoglobulinemia, osteosclerotic myeloma, peripheral neuropathy ...

10. Phase I Trial of Sargramostim and Nivolumab for Metastatic Melanoma to the Lung - Mayo Clinic

    3.29c History of severe hypersensitivity reactions to sargramostim or monoclonal antibodies. 3.29d Prior history of Grade 4 immune related adverse event ...